Abstract:The vast diversity of microbial communities reside in various locations of the human body, and they are collectively named as the ‘Human Microbiota.’ The majority of those microbes are found in the gastrointestinal and respiratory tracts. The microorganisms present in the gastrointestinal and the respiratory tracts are called the gut microbiota and the airway microbiota, respectively. These microbial communities are known to affect both the metabolic functions and the immune responses of the host. Among multiple factors determining the composition of gut microbiota, diet has played a pivotal role. The gut microbes possess enzymatic machinery for assimilating dietary fibers and releasing different metabolites, primarily short-chain fatty acids (SCFAs). The SCFAs modulate the immune responses of not only the gut but other distal mucosal sites as well, such as the lungs. Dysbiosis in normal gut flora is one of the factors involved in the development of asthma and other respiratory disorders. Of note, several human and murine studies have indicated significant cross-talk between gut microbiota and lung immunity, known as the gut–lung axis. Here, in this review, we summarize the recent state of the field concerning the effect of dietary metabolites, particularly SCFAs, on the “gut–lung axis” as well as discuss its impact on lung health. Moreover, we have highlighted the role of the “gut–lung axis” in SARS-CoV-2 mediated inflammation. Also, to analyze the global research progress on the gut–lung axis and to identify the knowledge gap in this field, we have also utilized the bibliographic tools Dimension database and VOS viewer analysis software. Through network mapping and visualization analysis, we can predict the present research trend and the possibility to explore new directions.

Bypassing the Gut–Lung Axis via Microbial Metabolites: Implications for Chronic Respiratory Diseases

The Intriguing Connection Between the Gut and Lung Microbiomes

Gut microbiota: A new insight into lung diseases

Diet, Microbiota and Gut-Lung Connection

Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics

Gut microbiome a promising target for management of respiratory diseases

The Influence of the Gut Microbiota on Host Health: A Focus on the Gut–Lung Axis and Therapeutic Approaches

COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics

A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases

Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches

Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections

Possible role of gut microbes and host’s immune response in gut–lung homeostasis

Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment

Gut Microbiota Modulation in the Management of Chronic Obstructive Pulmonary Disease: A Literature Review

Application of Microbiome-Based Therapies in Chronic Respiratory Diseases

The gut–airway microbiome axis in health and respiratory diseases

Impact of gut microbiota on immune reactions relevant to lung pathologies

The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections

Lung and Gut Affair

Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections

The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases